Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Growth 2022-2028
As the global economy mends, the 2021 growth of 23-Valent Pneumococcal Polysaccharide Vaccine will have significant change from previous year. According to our latest study, the global 23-Valent Pneumococcal Polysaccharide Vaccine market size is USD million in 2022 from USD 2661.4 million in 2021, with a change of % between 2021 and 2022. The global 23-Valent Pneumococcal Polysaccharide Vaccine market size will reach USD 7052.8 million in 2028, growing at a CAGR of 14.9% over the analysis period.
The United States 23-Valent Pneumococcal Polysaccharide Vaccine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global 23-Valent Pneumococcal Polysaccharide Vaccine market, reaching US$ million by the year 2028. As for the Europe 23-Valent Pneumococcal Polysaccharide Vaccine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main 23-Valent Pneumococcal Polysaccharide Vaccine players cover MSD, Sanofipasteur, CDIBP, and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of 23-Valent Pneumococcal Polysaccharide Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Single Dose Vial
Pre-filled Syringe
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
For Children (2-10)
For Person (10-64)
For The Old (Above or equal to 65)
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
MSD
Sanofipasteur
CDIBP
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for 23-Valent Pneumococcal Polysaccharide Vaccine by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for 23-Valent Pneumococcal Polysaccharide Vaccine by Country/Region, 2017, 2022 & 2028
2.2 23-Valent Pneumococcal Polysaccharide Vaccine Segment by Type
2.2.1 Single Dose Vial
2.2.2 Pre-filled Syringe
2.3 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type
2.3.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2017-2022)
2.3.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Market Share by Type (2017-2022)
2.3.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale Price by Type (2017-2022)
2.4 23-Valent Pneumococcal Polysaccharide Vaccine Segment by Application
2.4.1 For Children (2-10)
2.4.2 For Person (10-64)
2.4.3 For The Old (Above or equal to 65)
2.5 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application
2.5.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale Market Share by Application (2017-2022)
2.5.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Market Share by Application (2017-2022)
2.5.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale Price by Application (2017-2022)
3 Global 23-Valent Pneumococcal Polysaccharide Vaccine by Company
3.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Breakdown Data by Company
3.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Annual Sales by Company (2020-2022)
3.1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Company (2020-2022)
3.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Annual Revenue by Company (2020-2022)
3.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Company (2020-2022)
3.2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Company (2020-2022)
3.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale Price by Company
3.4 Key Manufacturers 23-Valent Pneumococcal Polysaccharide Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers 23-Valent Pneumococcal Polysaccharide Vaccine Product Location Distribution
3.4.2 Players 23-Valent Pneumococcal Polysaccharide Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for 23-Valent Pneumococcal Polysaccharide Vaccine by Geographic Region
4.1 World Historic 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Geographic Region (2017-2022)
4.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Annual Sales by Geographic Region (2017-2022)
4.1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Annual Revenue by Geographic Region
4.2 World Historic 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country/Region (2017-2022)
4.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Annual Sales by Country/Region (2017-2022)
4.2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Annual Revenue by Country/Region
4.3 Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth
4.4 APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth
4.5 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth
4.6 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth
5 Americas
5.1 Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country
5.1.1 Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2017-2022)
5.1.2 Americas 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2017-2022)
5.2 Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type
5.3 Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region
6.1.1 APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2017-2022)
6.1.2 APAC 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2017-2022)
6.2 APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type
6.3 APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine by Country
7.1.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2017-2022)
7.1.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2017-2022)
7.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type
7.3 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine by Country
8.1.1 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2017-2022)
8.1.2 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2017-2022)
8.2 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type
8.3 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine
10.3 Manufacturing Process Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine
10.4 Industry Chain Structure of 23-Valent Pneumococcal Polysaccharide Vaccine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 23-Valent Pneumococcal Polysaccharide Vaccine Distributors
11.3 23-Valent Pneumococcal Polysaccharide Vaccine Customer
12 World Forecast Review for 23-Valent Pneumococcal Polysaccharide Vaccine by Geographic Region
12.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Forecast by Region
12.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Forecast by Region (2023-2028)
12.1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global 23-Valent Pneumococcal Polysaccharide Vaccine Forecast by Type
12.7 Global 23-Valent Pneumococcal Polysaccharide Vaccine Forecast by Application
13 Key Players Analysis
13.1 MSD
13.1.1 MSD Company Information
13.1.2 MSD 23-Valent Pneumococcal Polysaccharide Vaccine Product Offered
13.1.3 MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 MSD Main Business Overview
13.1.5 MSD Latest Developments
13.2 Sanofipasteur
13.2.1 Sanofipasteur Company Information
13.2.2 Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Product Offered
13.2.3 Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Sanofipasteur Main Business Overview
13.2.5 Sanofipasteur Latest Developments
13.3 CDIBP
13.3.1 CDIBP Company Information
13.3.2 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Product Offered
13.3.3 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 CDIBP Main Business Overview
13.3.5 CDIBP Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. 23-Valent Pneumococcal Polysaccharide Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. 23-Valent Pneumococcal Polysaccharide Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Single Dose Vial
Table 4. Major Players of Pre-filled Syringe
Table 5. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2017-2022) & (K Dose)
Table 6. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2017-2022)
Table 7. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2017-2022) & ($ million)
Table 8. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2017-2022)
Table 9. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale Price by Type (2017-2022) & (US$/Dose)
Table 10. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2017-2022) & (K Dose)
Table 11. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2017-2022)
Table 12. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2017-2022)
Table 13. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application (2017-2022)
Table 14. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale Price by Application (2017-2022) & (US$/Dose)
Table 15. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Company (2020-2022) & (K Dose)
Table 16. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Company (2020-2022)
Table 17. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Company (2020-2022) ($ Millions)
Table 18. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Company (2020-2022)
Table 19. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale Price by Company (2020-2022) & (US$/Dose)
Table 20. Key Manufacturers 23-Valent Pneumococcal Polysaccharide Vaccine Producing Area Distribution and Sales Area
Table 21. Players 23-Valent Pneumococcal Polysaccharide Vaccine Products Offered
Table 22. 23-Valent Pneumococcal Polysaccharide Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Geographic Region (2017-2022) & (K Dose)
Table 26. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share Geographic Region (2017-2022)
Table 27. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country/Region (2017-2022) & (K Dose)
Table 30. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country/Region (2017-2022)
Table 31. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2017-2022) & (K Dose)
Table 34. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2017-2022)
Table 35. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2017-2022)
Table 37. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2017-2022) & (K Dose)
Table 38. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2017-2022)
Table 39. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2017-2022) & (K Dose)
Table 40. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2017-2022)
Table 41. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2017-2022) & (K Dose)
Table 42. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2017-2022)
Table 43. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2017-2022)
Table 45. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2017-2022) & (K Dose)
Table 46. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2017-2022)
Table 47. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2017-2022) & (K Dose)
Table 48. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2017-2022)
Table 49. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2017-2022) & (K Dose)
Table 50. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2017-2022)
Table 51. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2017-2022)
Table 53. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2017-2022) & (K Dose)
Table 54. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2017-2022)
Table 55. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2017-2022) & (K Dose)
Table 56. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2017-2022) & (K Dose)
Table 58. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2017-2022) & (K Dose)
Table 62. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2017-2022) & (K Dose)
Table 64. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of 23-Valent Pneumococcal Polysaccharide Vaccine
Table 66. Key Market Challenges & Risks of 23-Valent Pneumococcal Polysaccharide Vaccine
Table 67. Key Industry Trends of 23-Valent Pneumococcal Polysaccharide Vaccine
Table 68. 23-Valent Pneumococcal Polysaccharide Vaccine Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. 23-Valent Pneumococcal Polysaccharide Vaccine Distributors List
Table 71. 23-Valent Pneumococcal Polysaccharide Vaccine Customer List
Table 72. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Region (2023-2028) & (K Dose)
Table 73. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Forecast by Region
Table 74. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Country (2023-2028) & (K Dose)
Table 77. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Region (2023-2028) & (K Dose)
Table 79. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Country (2023-2028) & (K Dose)
Table 81. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Country (2023-2028) & (K Dose)
Table 83. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Type (2023-2028) & (K Dose)
Table 85. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share Forecast by Type (2023-2028)
Table 86. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Application (2023-2028) & (K Dose)
Table 89. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share Forecast by Application (2023-2028)
Table 90. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share Forecast by Application (2023-2028)
Table 92. MSD Basic Information, 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. MSD 23-Valent Pneumococcal Polysaccharide Vaccine Product Offered
Table 94. MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 95. MSD Main Business
Table 96. MSD Latest Developments
Table 97. Sanofipasteur Basic Information, 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Product Offered
Table 99. Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 100. Sanofipasteur Main Business
Table 101. Sanofipasteur Latest Developments
Table 102. CDIBP Basic Information, 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Product Offered
Table 104. CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 105. CDIBP Main Business
Table 106. CDIBP Latest Developments
List of Figures
Figure 1. Picture of 23-Valent Pneumococcal Polysaccharide Vaccine
Figure 2. 23-Valent Pneumococcal Polysaccharide Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth Rate 2017-2028 (K Dose)
Figure 7. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Single Dose Vial
Figure 10. Product Picture of Pre-filled Syringe
Figure 11. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type in 2021
Figure 12. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2017-2022)
Figure 13. 23-Valent Pneumococcal Polysaccharide Vaccine Consumed in For Children (2-10)
Figure 14. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market: For Children (2-10) (2017-2022) & (K Dose)
Figure 15. 23-Valent Pneumococcal Polysaccharide Vaccine Consumed in For Person (10-64)
Figure 16. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market: For Person (10-64) (2017-2022) & (K Dose)
Figure 17. 23-Valent Pneumococcal Polysaccharide Vaccine Consumed in For The Old (Above or equal to 65)
Figure 18. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market: For The Old (Above or equal to 65) (2017-2022) & (K Dose)
Figure 19. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2017-2022)
Figure 20. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application in 2021
Figure 21. 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market by Company in 2021 ($ Million)
Figure 22. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Company in 2021
Figure 23. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Geographic Region in 2021
Figure 25. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2017-2022)
Figure 26. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country/Region in 2021
Figure 27. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales 2017-2022 (K Dose)
Figure 28. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Revenue 2017-2022 ($ Millions)
Figure 29. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales 2017-2022 (K Dose)
Figure 30. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Revenue 2017-2022 ($ Millions)
Figure 31. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales 2017-2022 (K Dose)
Figure 32. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales 2017-2022 (K Dose)
Figure 34. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue 2017-2022 ($ Millions)
Figure 35. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country in 2021
Figure 36. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country in 2021
Figure 37. United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region in 2021
Figure 42. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Regions in 2021
Figure 43. China 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 47. India 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country in 2021
Figure 50. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country in 2021
Figure 51. Germany 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 52. France 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country in 2021
Figure 57. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country in 2021
Figure 58. Egypt 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine in 2021
Figure 64. Manufacturing Process Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine
Figure 65. Industry Chain Structure of 23-Valent Pneumococcal Polysaccharide Vaccine
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
